US 8158617
Fused heterocyclic compound and use thereof
granted A61KA61K31/00A61K31/4353
Quick answer
US patent 8158617 (Fused heterocyclic compound and use thereof) held by Takeda Pharmaceutical Company Limited expires Mon Apr 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Apr 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/00, A61K31/4353, A61K31/553, A61P